Last 12 months
Inside the activity.
0 purchase rows · 202 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 36 |
| Dec 2025 | 0 | 34 |
| Jan 2026 | 0 | 66 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 17 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 13 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 10 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 24 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 23, 2022 Filed Dec 29, 2022 01:00 UTC |
Sukhija RemyChief Commercial Officer
|
Exercise / conversionCommon Stock | 30,000 | $60.26 | $1,807,800.00 |
DisclosureSEC source: 0000899243-22-039463 · doc4.xml · nonDerivative · entry 1 Sukhija Remy · CIK 0001806949 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. After giving effect to these transactions, the reporting person's Rule 10b5-1 trading plan has been concluded and no more trading will be conducted thereunder. Read SEC document |
| August 10, 2022 Filed Aug 12, 2022 20:30 UTC |
Lynch Brian JosephSVP and General Counsel
|
GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $73.75 | $0.00 |
DisclosureSEC source: 0000899243-22-028491 · doc4.xml · derivative · entry 1 Lynch Brian Joseph · CIK 0001776196 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2032-08-10 F1 · derivative.exercise_date: The option vests as to 25% of the shares on the first anniversary of the date of grant (08/10/2023) and, thereafter, 6.25% of the shares shall vest on the last day of each successive three month period, provided the Reporting Person continues in service with the Issuer on each such date. Read SEC document |
| June 16, 2022 Filed Jun 21, 2022 06:30 UTC |
CRAVES FRED BDirector
|
GrantStock Option (Right to Buy) · Derivative | 9,470 | $0.00 Strike: $65.06 | $0.00 |
DisclosureSEC source: 0000899243-22-023232 · doc4.xml · derivative · entry 1 CRAVES FRED B · CIK 0001014095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,470 Underlying: Common Stock · 9,470 shares Expires 2025-06-16 F1 · derivative.exercise_date: The option vests as to 100% of underlying shares on the first anniversary of the grant date, provided that the Reporting Person continues to serve as a director of the Issuer until such anniversary date. Read SEC document |
| June 16, 2022 Filed Jun 21, 2022 10:30 UTC |
BATE KENNETHDirector
|
GrantStock Option (Right to Buy) · Derivative | 9,470 | $0.00 Strike: $65.06 | $0.00 |
DisclosureSEC source: 0000899243-22-023234 · doc4.xml · derivative · entry 1 BATE KENNETH · CIK 0001210238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,470 Underlying: Common Stock · 9,470 shares Expires 2025-06-16 F1 · derivative.exercise_date: The option vests as to 100% of underlying shares on the first anniversary of the grant date, provided that the Reporting Person continues to serve as a director of the Issuer until such anniversary date. Read SEC document |
| June 16, 2022 Filed Jun 21, 2022 10:30 UTC |
MILLIGAN DAVID VDirector
|
GrantStock Option (Right to buy) · Derivative | 9,470 | $0.00 Strike: $65.06 | $0.00 |
DisclosureSEC source: 0000899243-22-023233 · doc4.xml · derivative · entry 1 MILLIGAN DAVID V · CIK 0001222252 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,470 Underlying: Common Stock · 9,470 shares Expires 2025-06-16 F1 · derivative.exercise_date: The option vests as to 100% of underlying shares on the first anniversary of the grant date, provided that the Reporting Person continues to serve as a director of the Issuer until such anniversary date. Read SEC document |
| June 16, 2022 Filed Jun 21, 2022 10:30 UTC |
Levy Richard SDirector
|
GrantStock Option (Right to buy) · Derivative | 9,470 | $0.00 Strike: $65.06 | $0.00 |
DisclosureSEC source: 0000899243-22-023231 · doc4.xml · derivative · entry 1 Levy Richard S · CIK 0001454983 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,470 Underlying: Common Stock · 9,470 shares Expires 2025-06-16 F1 · derivative.exercise_date: The option vests as to 100% of underlying shares on the first anniversary of the grant date, provided that the Reporting Person continues to serve as a director of the Issuer until such anniversary date. Read SEC document |
| June 16, 2022 Filed Jun 21, 2022 10:30 UTC |
Daly James MDirector
|
GrantStock Option (Right to Buy) · Derivative | 9,470 | $0.00 Strike: $65.06 | $0.00 |
DisclosureSEC source: 0000899243-22-023230 · doc4.xml · derivative · entry 1 Daly James M · CIK 0001560782 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,470 Underlying: Common Stock · 9,470 shares Expires 2025-06-16 F1 · derivative.exercise_date: The option vests as to 100% of underlying shares on the first anniversary of the grant date, provided that the Reporting Person continues to serve as a director of the Issuer until such anniversary date. Read SEC document |
| June 16, 2022 Filed Jun 21, 2022 10:30 UTC |
Gollust Keith RDirector
|
GrantStock Option (Right to Buy) · Derivative | 9,470 | $0.00 Strike: $65.06 | $0.00 |
DisclosureSEC source: 0000899243-22-023229 · doc4.xml · derivative · entry 1 Gollust Keith R · CIK 0001325712 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,470 Underlying: Common Stock · 9,470 shares Expires 2025-06-16 F1 · derivative.exercise_date: The option vests as to 100% of underlying shares on the first anniversary of the grant date, provided that the Reporting Person continues to serve as a director of the Issuer until such anniversary date. Read SEC document |
| February 24, 2022 Filed Feb 25, 2022 01:17 UTC |
Waltermire Robert E.Senior VP, Chief Pharma Dev.
|
GrantCall Option · Derivative | 12,250 | $0.00 Strike: $87.09 | $0.00 |
DisclosureSEC source: 0000899243-22-007774 · doc4.xml · derivative · entry 1 Waltermire Robert E. · CIK 0001876996 · Senior VP, Chief Pharma Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,250 Underlying: Common Stock · 12,250 shares Expires 2022-02-24 F1 · derivative.exercise_date: The option vests as to 25% of the shares on the first anniversary of the date of grant (02/24/2023) and, thereafter, 6.25% of the shares shall vest on the last day of each successive three month period, provided the Reporting Person continues in service with the Issuer on each such date. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 01:40 UTC |
Howarth Alex G.Chief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 45,000 | $0.00 Strike: $87.09 | $0.00 |
DisclosureSEC source: 0000899243-22-007779 · doc4.xml · derivative · entry 1 Howarth Alex G. · CIK 0001795798 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2032-02-22 F1 · derivative.exercise_date: The option vests as to 25% of the shares on the first anniversary of the date of grant (02/22/2023) and, thereafter, 6.25% of the shares shall vest on the last day of each successive three month period, provided the Reporting Person continues in service with the Issuer on each such date. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 01:18 UTC |
Lynch Brian JosephSVP and General Councel
|
GrantStock Option (Right to Buy) · Derivative | 45,000 | $0.00 Strike: $87.09 | $0.00 |
DisclosureSEC source: 0000899243-22-007776 · doc4.xml · derivative · entry 1 Lynch Brian Joseph · CIK 0001776196 · SVP and General Councel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2032-02-22 F1 · derivative.exercise_date: The option vests as to 25% of the shares on the first anniversary of the date of grant (02/22/2023) and, thereafter, 6.25% of the shares shall vest on the last day of each successive three month period, provided the Reporting Person continues in service with the Issuer on each such date. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 01:18 UTC |
Sukhija RemyChief Commercial Officer
|
GrantStock Option (Right to Buy) · Derivative | 45,000 | $0.00 Strike: $87.09 | $0.00 |
DisclosureSEC source: 0000899243-22-007775 · doc4.xml · derivative · entry 1 Sukhija Remy · CIK 0001806949 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2032-02-22 F1 · derivative.exercise_date: The option vests as to 25% of the shares on the first anniversary of the date of grant (02/22/2023) and, thereafter, 6.25% of the shares shall vest on the last day of each successive three month period, provided the Reporting Person continues in service with the Issuer on each such date. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 01:12 UTC |
Taub RebeccaDirector · See Remarks
|
GrantStock Option (Right to Buy) · Derivative | 61,500 | $0.00 Strike: $87.09 | $0.00 |
DisclosureSEC source: 0000899243-22-007769 · doc4.xml · derivative · entry 1 Taub Rebecca · CIK 0001423898 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,500 Underlying: Common Stock · 61,500 shares Expires 2032-02-22 F1 · derivative.exercise_date: The option vests as to 25% of the shares on the first anniversary of the date of grant (02/22/2023) and, thereafter, 6.25% of the shares shall vest on the last day of each successive three month period, provided the Reporting Person continues in service with the Issuer on each such date. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 01:10 UTC |
FRIEDMAN PAUL ADirector · Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 70,000 | $0.00 Strike: $87.09 | $0.00 |
DisclosureSEC source: 0000899243-22-007766 · doc4.xml · derivative · entry 1 FRIEDMAN PAUL A · CIK 0001236927 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 70,000 shares Expires 2032-02-22 F1 · derivative.exercise_date: The option vests as to 25% of the shares on the first anniversary of the date of grant (02/22/2023) and, thereafter, 6.25% of the shares shall vest on the last day of each successive three month period, provided the Reporting Person continues in service with the Issuer on each such date. Read SEC document |
| December 31, 2021 Filed Feb 2, 2022 16:05 UTC |
CRAVES FRED BDirector · 10% owner
|
GiftCommon Stock | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-004133 · doc5.xml · nonDerivative · entry 1 CRAVES FRED B · CIK 0001014095 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 361,358 F1 · kind: Represents a bona fide gift of 3,000 shares of common stock from Dr. Craves to the Fred Craves Family Foundation. Read SEC document |
| December 03, 2021 Filed Dec 7, 2021 16:30 UTC |
CRAVES FRED BDirector · 10% owner
|
OtherCommon Stock | 24,172 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-047115 · doc4.xml · nonDerivative · entry 3 CRAVES FRED B · CIK 0001014095 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 1,261 F7 · kind: Represents transfers, without the payment of any consideration, to their partners and employees. F1 · ownership.nature: Bay City Capital LLC, a Delaware limited liability company ("BCC"), Bay City Capital Management IV LLC, a Delaware limited liability company ("Management IV"), Bay City Capital Fund IV, L.P., a Delaware limited partnership ("Fund IV"), and Bay City Capital Fund IV Co-Investment Fund, L.P., a Delaware limited partnership ("Co-Investment IV") are deemed to be a "group" for the purposes of Section 13(d) under the Securities Exchange Act of 1934. Management IV is the general partner of Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. BCC, the manager of Management IV, is also an advisor to Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. F4 · ownership.nature: These securities are held by BCC. Dr. Craves disclaims beneficial ownership of these securities held by BCC, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such shares, except to the extent of his pecuniary interest, if any, in the securities by virtue of the limited liability company interests he owns in BCC. Read SEC document |
| December 03, 2021 Filed Dec 7, 2021 16:30 UTC |
CRAVES FRED BDirector · 10% owner
|
OtherCommon Stock | 49,730 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-047115 · doc4.xml · nonDerivative · entry 2 CRAVES FRED B · CIK 0001014095 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 0 F7 · kind: Represents transfers, without the payment of any consideration, to their partners and employees. F7 · acquired: Represents transfers, without the payment of any consideration, to their partners and employees. F1 · ownership.nature: Bay City Capital LLC, a Delaware limited liability company ("BCC"), Bay City Capital Management IV LLC, a Delaware limited liability company ("Management IV"), Bay City Capital Fund IV, L.P., a Delaware limited partnership ("Fund IV"), and Bay City Capital Fund IV Co-Investment Fund, L.P., a Delaware limited partnership ("Co-Investment IV") are deemed to be a "group" for the purposes of Section 13(d) under the Securities Exchange Act of 1934. Management IV is the general partner of Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. BCC, the manager of Management IV, is also an advisor to Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. F3 · ownership.nature: These securities were held by Co-Investment IV. Dr. Craves disclaims beneficial ownership of these securities previously held by Co-Investment IV, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such shares, except to the extent of his pecuniary interest, if any, in the securities by virtue of the limited liability company interests he owns in BCC. Read SEC document |
| December 03, 2021 Filed Dec 7, 2021 16:30 UTC |
CRAVES FRED BDirector · 10% owner
|
OtherCommon Stock | 750,270 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-047115 · doc4.xml · nonDerivative · entry 1 CRAVES FRED B · CIK 0001014095 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 1,510,521 F7 · kind: Represents transfers, without the payment of any consideration, to their partners and employees. F1 · ownership.nature: Bay City Capital LLC, a Delaware limited liability company ("BCC"), Bay City Capital Management IV LLC, a Delaware limited liability company ("Management IV"), Bay City Capital Fund IV, L.P., a Delaware limited partnership ("Fund IV"), and Bay City Capital Fund IV Co-Investment Fund, L.P., a Delaware limited partnership ("Co-Investment IV") are deemed to be a "group" for the purposes of Section 13(d) under the Securities Exchange Act of 1934. Management IV is the general partner of Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. BCC, the manager of Management IV, is also an advisor to Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. F2 · ownership.nature: These securities are held by Fund IV. Dr. Craves disclaims beneficial ownership of these securities held by Fund IV, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such shares, except to the extent of his pecuniary interest, if any, in the securities by virtue of the limited liability company interests he owns in BCC. Read SEC document |
| December 03, 2021 Filed Dec 7, 2021 21:30 UTC |
BAY CITY CAPITAL LLC10% owner
Bay City Capital Management IV LLC10% owner
Bay City Capital Fund IV, L.P.10% owner
|
OtherCommon Stock | 24,172 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-047117 · doc4.xml · nonDerivative · entry 3 BAY CITY CAPITAL LLC · CIK 0001288452 · 10% owner Bay City Capital Management IV LLC · CIK 0001359070 · 10% owner Bay City Capital Fund IV, L.P. · CIK 0001360243 · 10% owner BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP · CIK 0001333817 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,261 F4 · kind: Represents transfers, without the payment of any consideration, to their partners and employees. F1 · ownership.direct: Bay City Capital LLC, a Delaware limited liability company ("BCC"), Bay City Capital Management IV LLC, a Delaware limited liability company ("Management IV"), Bay City Capital Fund IV, L.P., a Delaware limited partnership ("Fund IV"), and Bay City Capital Fund IV Co-Investment Fund, L.P., a Delaware limited partnership ("Co-Investment IV") are deemed to be a "group" for the purposes of Section 13(d) under the Securities Exchange Act of 1934. Management IV is the general partner of Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. BCC, the manager of Management IV, is also an advisor to Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. Read SEC document |
| December 03, 2021 Filed Dec 7, 2021 21:30 UTC |
BAY CITY CAPITAL LLC10% owner
Bay City Capital Management IV LLC10% owner
Bay City Capital Fund IV, L.P.10% owner
|
OtherCommon Stock | 49,730 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-047117 · doc4.xml · nonDerivative · entry 2 BAY CITY CAPITAL LLC · CIK 0001288452 · 10% owner Bay City Capital Management IV LLC · CIK 0001359070 · 10% owner Bay City Capital Fund IV, L.P. · CIK 0001360243 · 10% owner BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP · CIK 0001333817 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 0 F4 · kind: Represents transfers, without the payment of any consideration, to their partners and employees. F1 · ownership.nature: Bay City Capital LLC, a Delaware limited liability company ("BCC"), Bay City Capital Management IV LLC, a Delaware limited liability company ("Management IV"), Bay City Capital Fund IV, L.P., a Delaware limited partnership ("Fund IV"), and Bay City Capital Fund IV Co-Investment Fund, L.P., a Delaware limited partnership ("Co-Investment IV") are deemed to be a "group" for the purposes of Section 13(d) under the Securities Exchange Act of 1934. Management IV is the general partner of Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. BCC, the manager of Management IV, is also an advisor to Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. F3 · ownership.nature: The securities were held by Co-Investment IV. Read SEC document |
| December 03, 2021 Filed Dec 7, 2021 21:30 UTC |
BAY CITY CAPITAL LLC10% owner
Bay City Capital Management IV LLC10% owner
Bay City Capital Fund IV, L.P.10% owner
|
OtherCommon Stock | 750,270 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-047117 · doc4.xml · nonDerivative · entry 1 BAY CITY CAPITAL LLC · CIK 0001288452 · 10% owner Bay City Capital Management IV LLC · CIK 0001359070 · 10% owner Bay City Capital Fund IV, L.P. · CIK 0001360243 · 10% owner BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP · CIK 0001333817 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 1,510,521 F4 · kind: Represents transfers, without the payment of any consideration, to their partners and employees. F1 · ownership.nature: Bay City Capital LLC, a Delaware limited liability company ("BCC"), Bay City Capital Management IV LLC, a Delaware limited liability company ("Management IV"), Bay City Capital Fund IV, L.P., a Delaware limited partnership ("Fund IV"), and Bay City Capital Fund IV Co-Investment Fund, L.P., a Delaware limited partnership ("Co-Investment IV") are deemed to be a "group" for the purposes of Section 13(d) under the Securities Exchange Act of 1934. Management IV is the general partner of Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. BCC, the manager of Management IV, is also an advisor to Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. F2 · ownership.nature: The securities are held by Fund IV. Read SEC document |
| November 01, 2021 Filed Nov 3, 2021 20:26 UTC |
Howarth Alex G.Chief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $81.95 | $0.00 |
DisclosureSEC source: 0000899243-21-042719 · doc4.xml · derivative · entry 1 Howarth Alex G. · CIK 0001795798 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2031-11-01 F1 · derivative.exercise_date: The option vests as to 25% of the shares on the first anniversary of the date of grant (11/1/2022) and, thereafter, 6.25% of the shares shall vest on the last day of each successive three month period, provided the Reporting Person continues in service with the Issuer on each such date. This option was granted under our 2015 stock plan at a regularly scheduled meeting of the Compensation Committee of our Board of Directors on November 1, 2021. Read SEC document |
| August 02, 2021 Filed Aug 5, 2021 01:46 UTC |
Waltermire Robert E.Senior VP, Chief Pharma Dev.
|
GrantCall Option · Derivative | 35,000 | $0.00 Strike: $87.92 | $0.00 |
DisclosureSEC source: 0000899243-21-031720 · doc4.xml · derivative · entry 1 Waltermire Robert E. · CIK 0001876996 · Senior VP, Chief Pharma Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2031-08-02 F1 · derivative.exercise_date: The option vests as to 25% of the shares on the first anniversary of the date of grant (08/02/2022) and, thereafter, 6.25% of the shares shall vest on the last day of each successive three month period, provided the Reporting Person continues in service with the Issuer on each such date. Read SEC document |
| June 17, 2021 Filed Jun 21, 2021 08:03 UTC |
CRAVES FRED BDirector
|
GrantStock Option (Right to Buy) · Derivative | 12,489 | $0.00 Strike: $105.08 | $0.00 |
DisclosureSEC source: 0000899243-21-024668 · doc4.xml · derivative · entry 1 CRAVES FRED B · CIK 0001014095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,489 Underlying: Common Stock · 12,489 shares Expires 2024-06-17 F1 · derivative.exercise_date: The option vests as to 100% of underlying shares on the first anniversary of the grant date, provided that the Reporting Person continues to serve as a director of the Issuer until such anniversary date. Read SEC document |
| June 17, 2021 Filed Jun 21, 2021 12:03 UTC |
Daly James MDirector
|
GrantStock Option (Right to Buy) · Derivative | 12,489 | $0.00 Strike: $105.08 | $0.00 |
DisclosureSEC source: 0000899243-21-024669 · doc4.xml · derivative · entry 1 Daly James M · CIK 0001560782 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,489 Underlying: Common Stock · 12,489 shares Expires 2024-06-17 F1 · derivative.exercise_date: The option vests as to 100% of underlying shares on the first anniversary of the grant date, provided that the Reporting Person continues to serve as a director of the Issuer until such anniversary date. Read SEC document |
| June 17, 2021 Filed Jun 21, 2021 12:02 UTC |
MILLIGAN DAVID VDirector
|
GrantStock Option (Right to buy) · Derivative | 12,489 | $0.00 Strike: $105.08 | $0.00 |
DisclosureSEC source: 0000899243-21-024666 · doc4.xml · derivative · entry 1 MILLIGAN DAVID V · CIK 0001222252 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,489 Underlying: Common Stock · 12,489 shares Expires 2024-06-17 F1 · derivative.exercise_date: The option vests as to 100% of underlying shares on the first anniversary of the grant date, provided that the Reporting Person continues to serve as a director of the Issuer until such anniversary date. Read SEC document |
| June 17, 2021 Filed Jun 21, 2021 12:02 UTC |
BATE KENNETHDirector
|
GrantStock Option (Right to Buy) · Derivative | 12,489 | $0.00 Strike: $105.08 | $0.00 |
DisclosureSEC source: 0000899243-21-024665 · doc4.xml · derivative · entry 1 BATE KENNETH · CIK 0001210238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,489 Underlying: Common Stock · 12,489 shares Expires 2024-06-17 F1 · derivative.exercise_date: The option vests as to 100% of underlying shares on the first anniversary of the grant date, provided that the Reporting Person continues to serve as a director of the Issuer until such anniversary date. Read SEC document |
| June 17, 2021 Filed Jun 21, 2021 12:00 UTC |
Gollust Keith RDirector
|
GrantStock Option (Right to Buy) · Derivative | 12,489 | $0.00 Strike: $105.08 | $0.00 |
DisclosureSEC source: 0000899243-21-024663 · doc4.xml · derivative · entry 1 Gollust Keith R · CIK 0001325712 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,489 Underlying: Common Stock · 12,489 shares Expires 2024-06-17 F1 · derivative.exercise_date: The option vests as to 100% of underlying shares on the first anniversary of the grant date, provided that the Reporting Person continues to serve as a director of the Issuer until such anniversary date. Read SEC document |
| June 17, 2021 Filed Jun 21, 2021 12:02 UTC |
Levy Richard SDirector
|
GrantStock Option (Right to buy) · Derivative | 12,489 | $0.00 Strike: $105.08 | $0.00 |
DisclosureSEC source: 0000899243-21-024664 · doc4.xml · derivative · entry 1 Levy Richard S · CIK 0001454983 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,489 Underlying: Common Stock · 12,489 shares Expires 2024-06-17 F1 · derivative.exercise_date: The option vests as to 100% of underlying shares on the first anniversary of the grant date, provided that the Reporting Person continues to serve as a director of the Issuer until such anniversary date. Read SEC document |
| May 17, 2021 Filed May 19, 2021 19:40 UTC |
Howarth Alex G.Chief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 65,000 | $0.00 Strike: $134.00 | $0.00 |
DisclosureSEC source: 0000899243-21-019909 · doc4.xml · derivative · entry 1 Howarth Alex G. · CIK 0001795798 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,000 Underlying: Common Stock · 65,000 shares Expires 2031-05-17 F1 · derivative.exercise_date: The option vests as to 25% of the shares on the first anniversary of the date of grant (05/17/2022) and, thereafter, 6.25% of the shares shall vest on the last day of each successive three month period, provided the Reporting Person continues in service with the Issuer on each such date. Read SEC document |
| February 22, 2021 Filed Feb 23, 2021 18:35 UTC |
FRIEDMAN PAUL ADirector · Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $119.49 | $0.00 |
DisclosureSEC source: 0000899243-21-007765 · doc4.xml · derivative · entry 1 FRIEDMAN PAUL A · CIK 0001236927 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2031-02-22 F1 · derivative.exercise_date: The option vests as to 25% of the shares on the first anniversary of the date of grant (02/22/2022) and, thereafter, 6.25% of the shares shall vest on the last day of each successive three month period, provided the Reporting Person continues in service with the Issuer on each such date. Read SEC document |
| February 22, 2021 Filed Feb 23, 2021 18:32 UTC |
Schneebaum Marc RChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 32,000 | $0.00 Strike: $119.49 | $0.00 |
DisclosureSEC source: 0000899243-21-007763 · doc4.xml · derivative · entry 1 Schneebaum Marc R · CIK 0001396871 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,000 Underlying: Common Stock · 32,000 shares Expires 2031-02-22 F1 · derivative.exercise_date: The option vests as to 25% of the shares on the first anniversary of the date of grant (02/22/2022) and, thereafter, 6.25% of the shares shall vest on the last day of each successive three month period, provided the Reporting Person continues in service with the Issuer on each such date. Read SEC document |
| February 22, 2021 Filed Feb 23, 2021 18:31 UTC |
Sukhija RemyChief Commercial Officer
|
GrantStock Option (Right to Buy) · Derivative | 24,000 | $0.00 Strike: $119.49 | $0.00 |
DisclosureSEC source: 0000899243-21-007761 · doc4.xml · derivative · entry 1 Sukhija Remy · CIK 0001806949 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,000 Underlying: Common Stock · 24,000 shares Expires 2031-02-22 F1 · derivative.exercise_date: The option vests as to 25% of the shares on the first anniversary of the date of grant (02/22/2022) and, thereafter, 6.25% of the shares shall vest on the last day of each successive three month period, provided the Reporting Person continues in service with the Issuer on each such date. Read SEC document |
| February 22, 2021 Filed Feb 23, 2021 18:29 UTC |
Lynch Brian JosephSVP and General Councel
|
GrantStock Option (Right to Buy) · Derivative | 32,000 | $0.00 Strike: $119.49 | $0.00 |
DisclosureSEC source: 0000899243-21-007759 · doc4.xml · derivative · entry 1 Lynch Brian Joseph · CIK 0001776196 · SVP and General Councel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,000 Underlying: Common Stock · 32,000 shares Expires 2031-02-22 F1 · derivative.exercise_date: The option vests as to 25% of the shares on the first anniversary of the date of grant (02/22/2022) and, thereafter, 6.25% of the shares shall vest on the last day of each successive three month period, provided the Reporting Person continues in service with the Issuer on each such date. Read SEC document |
| February 22, 2021 Filed Feb 23, 2021 18:28 UTC |
Taub RebeccaDirector · See Remarks
|
GrantStock Option (Right to Buy) · Derivative | 44,000 | $0.00 Strike: $119.49 | $0.00 |
DisclosureSEC source: 0000899243-21-007758 · doc4.xml · derivative · entry 1 Taub Rebecca · CIK 0001423898 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,000 Underlying: Common Stock · 44,000 shares Expires 2031-02-22 F1 · derivative.exercise_date: The option vests as to 25% of the shares on the first anniversary of the date of grant (02/22/2022) and, thereafter, 6.25% of the shares shall vest on the last day of each successive three month period, provided the Reporting Person continues in service with the Issuer on each such date. Read SEC document |
| December 30, 2020 Filed Feb 11, 2021 15:50 UTC |
CRAVES FRED BDirector · 10% owner
|
GiftCommon Stock | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-005912 · doc5.xml · nonDerivative · entry 2 CRAVES FRED B · CIK 0001014095 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 317,579 F3 · kind: Represents a bona fide gift of 15,000 shares of common stock from Dr. Craves to the Fred Craves Family Foundation. F4 · balance_after: Reflects a transfer of 43,537 shares of common stock from BCC to Dr. Craves and a transfer of 80,974 shares of common stock from Dr. Craves to a former spouse pursuant to a court approved divorce settlement agreement. F3 · ownership.direct: Represents a bona fide gift of 15,000 shares of common stock from Dr. Craves to the Fred Craves Family Foundation. F4 · ownership.direct: Reflects a transfer of 43,537 shares of common stock from BCC to Dr. Craves and a transfer of 80,974 shares of common stock from Dr. Craves to a former spouse pursuant to a court approved divorce settlement agreement. Read SEC document |
| December 01, 2020 Filed Dec 2, 2020 02:36 UTC |
BAY CITY CAPITAL LLC10% owner
Bay City Capital Management IV LLC10% owner
Bay City Capital Fund IV, L.P.10% owner
|
OtherCommon Stock | 43,537 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-032411 · doc4.xml · nonDerivative · entry 1 BAY CITY CAPITAL LLC · CIK 0001288452 · 10% owner Bay City Capital Management IV LLC · CIK 0001359070 · 10% owner Bay City Capital Fund IV, L.P. · CIK 0001360243 · 10% owner BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP · CIK 0001333817 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 2,310,521 F1 · kind: Represents a transfer, without the payment of any consideration, to an affiliate. F1 · ownership.nature: Represents a transfer, without the payment of any consideration, to an affiliate. F2 · ownership.nature: Includes 2,260,791 shares of common stock held by Bay City Capital Fund IV, L.P., a Delaware limited partnership ("Fund IV"), and 49,730 shares of common stock held by Bay City Capital Fund IV Co-Investment Fund, L.P., a Delaware limited partnership ("Co-Investment IV"). Bay City Capital LLC, a Delaware limited liability company ("BCC"), Bay City Capital Management IV LLC, a Delaware limited liability company ("Management IV"), Fund IV and Co-Investment IV are deemed to be a "group" for the purposes of Section 13(d) under the Securities Exchange Act of 1934. Management IV is the general partner of Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. BCC, the manager of Management IV, is also an advisor to Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. Read SEC document |
| September 04, 2020 Filed Sep 4, 2020 21:06 UTC |
CRAVES FRED BDirector · 10% owner
|
OtherCommon Stock | 45,460 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-024410 · doc4.xml · nonDerivative · entry 3 CRAVES FRED B · CIK 0001014095 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 43,537 F6 · kind: Represents transfers, without the payment of any consideration, to their partners and employees. F6 · shares: Represents transfers, without the payment of any consideration, to their partners and employees. F6 · price: Represents transfers, without the payment of any consideration, to their partners and employees. F6 · acquired: Represents transfers, without the payment of any consideration, to their partners and employees. F1 · ownership.nature: Bay City Capital LLC, a Delaware limited liability company ("BCC"), Bay City Capital Management IV LLC, a Delaware limited liability company ("Management IV"), Bay City Capital Fund IV, L.P., a Delaware limited partnership ("Fund IV"), and Bay City Capital Fund IV Co-Investment Fund, L.P., a Delaware limited partnership ("Co-Investment IV") are deemed to be a "group" for the purposes of Section 13(d) under the Securities Exchange Act of 1934. Management IV is the general partner of Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. BCC, the manager of Management IV, is also an advisor to Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. F4 · ownership.nature: These securities are held by BCC. Dr. Craves disclaims beneficial ownership of these securities held by BCC, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such shares, except to the extent of his pecuniary interest, if any, in the securities by virtue of the limited liability company interests he owns in BCC. Read SEC document |
| September 04, 2020 Filed Sep 4, 2020 21:06 UTC |
CRAVES FRED BDirector · 10% owner
|
OtherCommon Stock | 31,650 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-024410 · doc4.xml · nonDerivative · entry 2 CRAVES FRED B · CIK 0001014095 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 49,730 F6 · kind: Represents transfers, without the payment of any consideration, to their partners and employees. F6 · shares: Represents transfers, without the payment of any consideration, to their partners and employees. F6 · price: Represents transfers, without the payment of any consideration, to their partners and employees. F6 · acquired: Represents transfers, without the payment of any consideration, to their partners and employees. F1 · ownership.nature: Bay City Capital LLC, a Delaware limited liability company ("BCC"), Bay City Capital Management IV LLC, a Delaware limited liability company ("Management IV"), Bay City Capital Fund IV, L.P., a Delaware limited partnership ("Fund IV"), and Bay City Capital Fund IV Co-Investment Fund, L.P., a Delaware limited partnership ("Co-Investment IV") are deemed to be a "group" for the purposes of Section 13(d) under the Securities Exchange Act of 1934. Management IV is the general partner of Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. BCC, the manager of Management IV, is also an advisor to Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. F3 · ownership.nature: These securities are held by Co-Investment IV. Dr. Craves disclaims beneficial ownership of these securities held by Co-Investment IV, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such shares, except to the extent of his pecuniary interest, if any, in the securities by virtue of the limited liability company interests he owns in BCC. Read SEC document |
| September 04, 2020 Filed Sep 4, 2020 21:06 UTC |
CRAVES FRED BDirector · 10% owner
|
OtherCommon Stock | 1,468,350 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-024410 · doc4.xml · nonDerivative · entry 1 CRAVES FRED B · CIK 0001014095 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 2,260,791 F6 · kind: Represents transfers, without the payment of any consideration, to their partners and employees. F6 · shares: Represents transfers, without the payment of any consideration, to their partners and employees. F6 · price: Represents transfers, without the payment of any consideration, to their partners and employees. F6 · acquired: Represents transfers, without the payment of any consideration, to their partners and employees. F1 · ownership.nature: Bay City Capital LLC, a Delaware limited liability company ("BCC"), Bay City Capital Management IV LLC, a Delaware limited liability company ("Management IV"), Bay City Capital Fund IV, L.P., a Delaware limited partnership ("Fund IV"), and Bay City Capital Fund IV Co-Investment Fund, L.P., a Delaware limited partnership ("Co-Investment IV") are deemed to be a "group" for the purposes of Section 13(d) under the Securities Exchange Act of 1934. Management IV is the general partner of Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. BCC, the manager of Management IV, is also an advisor to Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. F2 · ownership.nature: These securities are held by Fund IV. Dr. Craves disclaims beneficial ownership of these securities held by Fund IV, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such shares, except to the extent of his pecuniary interest, if any, in the securities by virtue of the limited liability company interests he owns in BCC. Read SEC document |
| September 04, 2020 Filed Sep 5, 2020 01:09 UTC |
BAY CITY CAPITAL LLC10% owner
Bay City Capital Management IV LLC10% owner
Bay City Capital Fund IV, L.P.10% owner
|
OtherCommon Stock | 45,460 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-024411 · doc4.xml · nonDerivative · entry 3 BAY CITY CAPITAL LLC · CIK 0001288452 · 10% owner Bay City Capital Management IV LLC · CIK 0001359070 · 10% owner Bay City Capital Fund IV, L.P. · CIK 0001360243 · 10% owner BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP · CIK 0001333817 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,537 F4 · kind: Represents transfers, without the payment of any consideration, to their partners and employees. F4 · shares: Represents transfers, without the payment of any consideration, to their partners and employees. F4 · price: Represents transfers, without the payment of any consideration, to their partners and employees. F4 · acquired: Represents transfers, without the payment of any consideration, to their partners and employees. F1 · ownership.direct: Bay City Capital LLC, a Delaware limited liability company ("BCC"), Bay City Capital Management IV LLC, a Delaware limited liability company ("Management IV"), Bay City Capital Fund IV, L.P., a Delaware limited partnership ("Fund IV"), and Bay City Capital Fund IV Co-Investment Fund, L.P., a Delaware limited partnership ("Co-Investment IV") are deemed to be a "group" for the purposes of Section 13(d) under the Securities Exchange Act of 1934. Management IV is the general partner of Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. BCC, the manager of Management IV, is also an advisor to Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. Read SEC document |
| September 04, 2020 Filed Sep 5, 2020 01:09 UTC |
BAY CITY CAPITAL LLC10% owner
Bay City Capital Management IV LLC10% owner
Bay City Capital Fund IV, L.P.10% owner
|
OtherCommon Stock | 31,650 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-024411 · doc4.xml · nonDerivative · entry 2 BAY CITY CAPITAL LLC · CIK 0001288452 · 10% owner Bay City Capital Management IV LLC · CIK 0001359070 · 10% owner Bay City Capital Fund IV, L.P. · CIK 0001360243 · 10% owner BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP · CIK 0001333817 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 49,730 F4 · kind: Represents transfers, without the payment of any consideration, to their partners and employees. F4 · shares: Represents transfers, without the payment of any consideration, to their partners and employees. F4 · price: Represents transfers, without the payment of any consideration, to their partners and employees. F4 · acquired: Represents transfers, without the payment of any consideration, to their partners and employees. F1 · ownership.nature: Bay City Capital LLC, a Delaware limited liability company ("BCC"), Bay City Capital Management IV LLC, a Delaware limited liability company ("Management IV"), Bay City Capital Fund IV, L.P., a Delaware limited partnership ("Fund IV"), and Bay City Capital Fund IV Co-Investment Fund, L.P., a Delaware limited partnership ("Co-Investment IV") are deemed to be a "group" for the purposes of Section 13(d) under the Securities Exchange Act of 1934. Management IV is the general partner of Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. BCC, the manager of Management IV, is also an advisor to Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. F3 · ownership.nature: The securities are held by Co-Investment IV. Read SEC document |
| September 04, 2020 Filed Sep 5, 2020 01:09 UTC |
BAY CITY CAPITAL LLC10% owner
Bay City Capital Management IV LLC10% owner
Bay City Capital Fund IV, L.P.10% owner
|
OtherCommon Stock | 1,468,350 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-024411 · doc4.xml · nonDerivative · entry 1 BAY CITY CAPITAL LLC · CIK 0001288452 · 10% owner Bay City Capital Management IV LLC · CIK 0001359070 · 10% owner Bay City Capital Fund IV, L.P. · CIK 0001360243 · 10% owner BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP · CIK 0001333817 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 2,260,791 F4 · kind: Represents transfers, without the payment of any consideration, to their partners and employees. F4 · shares: Represents transfers, without the payment of any consideration, to their partners and employees. F4 · price: Represents transfers, without the payment of any consideration, to their partners and employees. F4 · acquired: Represents transfers, without the payment of any consideration, to their partners and employees. F1 · ownership.nature: Bay City Capital LLC, a Delaware limited liability company ("BCC"), Bay City Capital Management IV LLC, a Delaware limited liability company ("Management IV"), Bay City Capital Fund IV, L.P., a Delaware limited partnership ("Fund IV"), and Bay City Capital Fund IV Co-Investment Fund, L.P., a Delaware limited partnership ("Co-Investment IV") are deemed to be a "group" for the purposes of Section 13(d) under the Securities Exchange Act of 1934. Management IV is the general partner of Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. BCC, the manager of Management IV, is also an advisor to Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. F2 · ownership.nature: The securities are held by Fund IV. Read SEC document |
| August 19, 2020 Filed Aug 19, 2020 19:40 UTC |
CRAVES FRED BDirector · 10% owner
|
SaleCommon Stock | 7,303 | $107.64 | $786,094.92 |
DisclosureSEC source: 0000899243-20-022971 · doc4.xml · nonDerivative · entry 3 CRAVES FRED B · CIK 0001014095 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 42,875 F1 · ownership.nature: Bay City Capital LLC, a Delaware limited liability company ("BCC"), Bay City Capital Management IV LLC, a Delaware limited liability company ("Management IV"), Bay City Capital Fund IV, L.P., a Delaware limited partnership ("Fund IV"), and Bay City Capital Fund IV Co-Investment Fund, L.P., a Delaware limited partnership ("Co-Investment IV") are deemed to be a "group" for the purposes of Section 13(d) under the Securities Exchange Act of 1934. Management IV is the general partner of Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. BCC, the manager of Management IV, is also an advisor to Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. F2 · ownership.nature: These securities are held by BCC. Dr. Craves disclaims beneficial ownership of these securities held by BCC, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such shares, except to the extent of his pecuniary interest, if any, in the securities by virtue of the limited liability company interests he owns in BCC. Read SEC document |
| August 19, 2020 Filed Aug 19, 2020 23:40 UTC |
BAY CITY CAPITAL LLC10% owner
Bay City Capital Management IV LLC10% owner
Bay City Capital Fund IV, L.P.10% owner
|
SaleCommon Stock | 7,303 | $107.64 | $786,094.92 |
DisclosureSEC source: 0000899243-20-022972 · doc4.xml · nonDerivative · entry 3 BAY CITY CAPITAL LLC · CIK 0001288452 · 10% owner Bay City Capital Management IV LLC · CIK 0001359070 · 10% owner Bay City Capital Fund IV, L.P. · CIK 0001360243 · 10% owner BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP · CIK 0001333817 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,875 F1 · ownership.direct: Bay City Capital LLC, a Delaware limited liability company ("BCC"), Bay City Capital Management IV LLC, a Delaware limited liability company ("Management IV"), Bay City Capital Fund IV, L.P., a Delaware limited partnership ("Fund IV"), and Bay City Capital Fund IV Co-Investment Fund, L.P., a Delaware limited partnership ("Co-Investment IV") are deemed to be a "group" for the purposes of Section 13(d) under the Securities Exchange Act of 1934. Management IV is the general partner of Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. BCC, the manager of Management IV, is also an advisor to Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. Read SEC document |
| August 18, 2020 Filed Aug 19, 2020 19:40 UTC |
CRAVES FRED BDirector · 10% owner
|
SaleCommon Stock | 10,197 | $110.03 | $1,121,975.91 |
DisclosureSEC source: 0000899243-20-022971 · doc4.xml · nonDerivative · entry 2 CRAVES FRED B · CIK 0001014095 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 50,178 F1 · ownership.nature: Bay City Capital LLC, a Delaware limited liability company ("BCC"), Bay City Capital Management IV LLC, a Delaware limited liability company ("Management IV"), Bay City Capital Fund IV, L.P., a Delaware limited partnership ("Fund IV"), and Bay City Capital Fund IV Co-Investment Fund, L.P., a Delaware limited partnership ("Co-Investment IV") are deemed to be a "group" for the purposes of Section 13(d) under the Securities Exchange Act of 1934. Management IV is the general partner of Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. BCC, the manager of Management IV, is also an advisor to Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. F2 · ownership.nature: These securities are held by BCC. Dr. Craves disclaims beneficial ownership of these securities held by BCC, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such shares, except to the extent of his pecuniary interest, if any, in the securities by virtue of the limited liability company interests he owns in BCC. Read SEC document |
| August 18, 2020 Filed Aug 19, 2020 23:40 UTC |
BAY CITY CAPITAL LLC10% owner
Bay City Capital Management IV LLC10% owner
Bay City Capital Fund IV, L.P.10% owner
|
SaleCommon Stock | 10,197 | $110.03 | $1,121,975.91 |
DisclosureSEC source: 0000899243-20-022972 · doc4.xml · nonDerivative · entry 2 BAY CITY CAPITAL LLC · CIK 0001288452 · 10% owner Bay City Capital Management IV LLC · CIK 0001359070 · 10% owner Bay City Capital Fund IV, L.P. · CIK 0001360243 · 10% owner BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP · CIK 0001333817 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,178 F1 · ownership.direct: Bay City Capital LLC, a Delaware limited liability company ("BCC"), Bay City Capital Management IV LLC, a Delaware limited liability company ("Management IV"), Bay City Capital Fund IV, L.P., a Delaware limited partnership ("Fund IV"), and Bay City Capital Fund IV Co-Investment Fund, L.P., a Delaware limited partnership ("Co-Investment IV") are deemed to be a "group" for the purposes of Section 13(d) under the Securities Exchange Act of 1934. Management IV is the general partner of Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. BCC, the manager of Management IV, is also an advisor to Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. Read SEC document |
| August 17, 2020 Filed Aug 19, 2020 19:40 UTC |
CRAVES FRED BDirector · 10% owner
|
SaleCommon Stock | 12,500 | $110.73 | $1,384,125.00 |
DisclosureSEC source: 0000899243-20-022971 · doc4.xml · nonDerivative · entry 1 CRAVES FRED B · CIK 0001014095 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 60,375 F1 · ownership.nature: Bay City Capital LLC, a Delaware limited liability company ("BCC"), Bay City Capital Management IV LLC, a Delaware limited liability company ("Management IV"), Bay City Capital Fund IV, L.P., a Delaware limited partnership ("Fund IV"), and Bay City Capital Fund IV Co-Investment Fund, L.P., a Delaware limited partnership ("Co-Investment IV") are deemed to be a "group" for the purposes of Section 13(d) under the Securities Exchange Act of 1934. Management IV is the general partner of Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. BCC, the manager of Management IV, is also an advisor to Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. F2 · ownership.nature: These securities are held by BCC. Dr. Craves disclaims beneficial ownership of these securities held by BCC, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such shares, except to the extent of his pecuniary interest, if any, in the securities by virtue of the limited liability company interests he owns in BCC. Read SEC document |
| August 17, 2020 Filed Aug 19, 2020 23:40 UTC |
BAY CITY CAPITAL LLC10% owner
Bay City Capital Management IV LLC10% owner
Bay City Capital Fund IV, L.P.10% owner
|
SaleCommon Stock | 12,500 | $110.73 | $1,384,125.00 |
DisclosureSEC source: 0000899243-20-022972 · doc4.xml · nonDerivative · entry 1 BAY CITY CAPITAL LLC · CIK 0001288452 · 10% owner Bay City Capital Management IV LLC · CIK 0001359070 · 10% owner Bay City Capital Fund IV, L.P. · CIK 0001360243 · 10% owner BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP · CIK 0001333817 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,375 F1 · ownership.direct: Bay City Capital LLC, a Delaware limited liability company ("BCC"), Bay City Capital Management IV LLC, a Delaware limited liability company ("Management IV"), Bay City Capital Fund IV, L.P., a Delaware limited partnership ("Fund IV"), and Bay City Capital Fund IV Co-Investment Fund, L.P., a Delaware limited partnership ("Co-Investment IV") are deemed to be a "group" for the purposes of Section 13(d) under the Securities Exchange Act of 1934. Management IV is the general partner of Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. BCC, the manager of Management IV, is also an advisor to Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. Read SEC document |
| August 06, 2020 Filed Aug 10, 2020 23:07 UTC |
Lynch Brian JosephSee Remarks
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $103.10 | $0.00 |
DisclosureSEC source: 0000899243-20-021949 · doc4.xml · derivative · entry 1 Lynch Brian Joseph · CIK 0001776196 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2030-08-06 F1 · derivative.exercise_date: The option vests as to 25% of the shares on the first anniversary of the date of grant (August 6, 2021) and, thereafter, 6.25% of the shares shall vest on the last day of each successive three month period, provided the Reporting Person continues in service with the Issuer on each such date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.